Myeloid-derived cells, as a multifunctional and highly heterogeneous cell population, have become the subject of extensive studies within the last five years, which has led to reconsideration or refining of the classic concepts of immune crosstalk in tumors and revision of the role of IFNg and other cytokines in tumor development [8,18,19,20]. This evidence concerns the gene IFNG and neoplasm.